These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37885171)

  • 21. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy.
    Shirley DA; Tornel W; Warren CA; Moonah S
    Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37560802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept.
    Tanaka Y; Tashiro S; Ikegami S; Enoki Y; Taguchi K; Matsumoto K
    Anaerobe; 2023 Dec; 84():102789. PubMed ID: 37879532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin Susceptibility.
    Greentree DH; Rice LB; Donskey CJ
    Clin Infect Dis; 2022 Oct; 75(9):1661-1664. PubMed ID: 35653393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral vancomycin prophylaxis against recurrent
    Zacharioudakis IM; Zervou FN; Dubrovskaya Y; Phillips MS
    Infect Control Hosp Epidemiol; 2020 Aug; 41(8):908-913. PubMed ID: 32539877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and management of children with Clostridioides difficile infection at a tertiary pediatric hospital in China.
    Li X; Xiao F; Li Y; Hu H; Xiao Y; Xu Q; Li D; Yu G; Wang Y; Zhang T
    Braz J Infect Dis; 2022; 26(4):102380. PubMed ID: 35753395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
    Nelson RL; Suda KJ; Evans CT
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
    Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
    J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant.
    Altemeier OJ; Konrardy KT
    Transpl Infect Dis; 2022 Apr; 24(2):e13790. PubMed ID: 35014136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clostridioides difficile infections].
    van Prehn J; Chernova VO; Vendrik KEW; Kuijper EJ
    Ned Tijdschr Geneeskd; 2023 Oct; 167():. PubMed ID: 37850615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of
    Knight EM; Schiller DS; Fulman MK; Rastogi R
    J Pharm Pract; 2020 Oct; 33(5):633-639. PubMed ID: 30744479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
    Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
    Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
    Sattler MM; Crews JD
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridioides difficile: Current overview and future perspectives.
    Giles J; Roberts A
    Adv Protein Chem Struct Biol; 2022; 129():215-245. PubMed ID: 35305720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary clostridium difficile infection in patients with ulcerative colitis: Case report and literature review.
    Gao X; Zhou H; Hu Z; Wang Q; Chen Y; Zh F; Zhou G
    Medicine (Baltimore); 2024 Feb; 103(6):e36693. PubMed ID: 38335423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.